Ajinomoto Co. Inc. (TYO:2802) is positioning cutting-edge operations as a driver of future business growth for its contract manufacturing of…...

Japan's leading chemical industry newspaper
Filed Under: Industry, Pharma Tagged With: Ajinomoto, Ajinomoto Bio-Pharma, antibodies, antibody drugs, antibody-drug conjugates, biopharmaceuticals, gene therapy, medicine, pharmaceutical
Ajinomoto Co. Inc. (TYO:2802) is positioning cutting-edge operations as a driver of future business growth for its contract manufacturing of…...